HIGHLIGHTED TOPIC Muscle Dysfunction in COPD The mechanisms of cachexia underlying muscle dysfunction in COPD

نویسندگان

  • A. H. V. Remels
  • H. R. Gosker
  • W. J. Schols
چکیده

Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol 114: 1253–1262, 2013. First published September 27, 2012; doi:10.1152/japplphysiol.00790.2012.—Pulmonary cachexia is a prevalent, debilitating, and well-recognized feature of COPD associated with increased mortality and loss of peripheral and respiratory muscle function. The exact cause and underlying mechanisms of cachexia in COPD are still poorly understood. Increasing evidence, however, shows that pathological changes in intracellular mechanisms of muscle mass maintenance (i.e., protein turnover and myonuclear turnover) are likely involved. Potential factors triggering alterations in these mechanisms in COPD include oxidative stress, myostatin, and inflammation. In addition to muscle wasting, peripheral muscle in COPD is characterized by a fiber-type shift toward a more type II, glycolytic phenotype and an impaired oxidative capacity (collectively referred to as an impaired oxidative phenotype). Atrophied diaphragm muscle in COPD, however, displays an enhanced oxidative phenotype. Interestingly, intrinsic abnormalities in (lower limb) peripheral muscle seem more pronounced in either cachectic patients or weight loss-susceptible emphysema patients, suggesting that muscle wasting and intrinsic changes in peripheral muscle’s oxidative phenotype are somehow intertwined. In this manuscript, we will review alterations in mechanisms of muscle mass maintenance in COPD and discuss the involvement of oxidative stress, inflammation, and myostatin as potential triggers of cachexia. Moreover, we postulate that an impaired muscle oxidative phenotype in COPD can accelerate the process of cachexia, as it renders muscle in COPD less energy efficient, thereby contributing to an energy deficit and weight loss when not dietary compensated. Furthermore, loss of peripheral muscle oxidative phenotype may increase the muscle’s susceptibility to inflammationand oxidative stress-induced muscle damage and wasting.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The mechanisms of cachexia underlying muscle dysfunction in COPD.

Pulmonary cachexia is a prevalent, debilitating, and well-recognized feature of COPD associated with increased mortality and loss of peripheral and respiratory muscle function. The exact cause and underlying mechanisms of cachexia in COPD are still poorly understood. Increasing evidence, however, shows that pathological changes in intracellular mechanisms of muscle mass maintenance (i.e., prote...

متن کامل

Evidence of Peripheral Muscle Dysfunction

early clinical manifestations of chronic obstructive pulmonary disease (COPD).1 As the disease progresses, several extrathoracic organs are affected, such that COPD is now recognized as a multisystem disease. Altered kidney and endothelial function,2 endocrine abnormalities,3 osteoporosis,4 and peripheral muscle dysfunction5 are now commonly reported in COPD. Among these extrathoracic manifesta...

متن کامل

Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

PURPOSE OF REVIEW The purpose of this review is to identify new advances in our understanding of skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease (COPD). RECENT FINDINGS Recent studies have confirmed the relevance of muscle dysfunction as an independent prognosis factor in COPD. Animal studies have shed light on the molecular mechanisms governing skeletal mus...

متن کامل

Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?

P eripheral muscle weakness is a common and serious complication of chronic obstructive pulmonary disease (COPD), which precedes loss of fat-free mass and is an independent predictor of mortality in patients with Global Initiative for COPD grade III or IV disease [1]. Current treatment options for muscle weakness are limited to exercise and supplemental feeding for cachectic patients. However, ...

متن کامل

HIGHLIGHTED TOPIC Muscle Dysfunction in COPD Metabolic derangements in COPD muscle dysfunction

Luis Puente-Maestu, Alberto Lázaro, and Blanca Humanes Servicio de Neumología, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; and Laboratorio de Nefrología Experimental, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, S...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013